AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffer, E. K.
Right arrow Articles by Fontaine, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffer, E. K.
Right arrow Articles by Fontaine, A. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2001; 176:1040-1042
© American Roentgen Ray Society


Technical Innovation

Treatment of Chylothorax

Percutaneous Catheterization and Embolization of the Thoracic Duct

Eric K. Hoffer1,2, Robert D. Bloch1, Michael S. Mulligan3, John J. Borsa1 and Arthur B. Fontaine1

1 Department of Radiology, Section of Vascular and Interventional Radiology, University of Washington Medical Center, 1949 Pacific Ave. N.E., Box 357115, Seattle, WA 98195.
2 Present address: Department of Radiology, Box 359728, Harborview Medical Center, 325 9th Ave., Seattle, WA 98104.
3 Department of Surgery, Division Cardiothoracic Surgery, University of Washington Medical Center, Seattle, WA 98195.

Received August 23, 2000; accepted after revision October 3, 2000.

 
Address correspondence to E. K. Hoffer.


Introduction
Top
Introduction
Subject and Methods
Discussion
References
 
Chylothorax is often a result of thoracic duct injury, which is an infrequent complication of esophageal surgery [1,2,3]. Although many cases are successfully treated conservatively, a high-output leak that persists longer than 5 days should be considered for surgical repair [4]. The mortality of repair through a thoracotomy can be as high as 25% [1, 2]. In 1999, Cope et al. [5] described a low-risk percutaneous approach to embolization of the thoracic duct via the cisterna chyli or retroperitoneal lymphatic vessels. Failures occurred in patients who did not have suitable retroperitoneal ducts for catheterization; this was seen in cases of prior abdominal surgery, trauma, chronic aortic dissection, or lymphagiomyomatosis. To our knowledge, there have been no reports of the use of this technique other than that of the original investigators. We describe a slight modification of the technique in a patient who had failed surgical repair.


Subject and Methods
Top
Introduction
Subject and Methods
Discussion
References
 
A 79-year-old man presented with progressive dysphagia. He had a history of antireflux surgery 16 years earlier and had undergone a colectomy with left cecostomy and adjuvant radiation therapy for colon cancer 18 years earlier. Dual-chamber pacemakers were placed 7 years before for sick sinus syndrome. The patient presented with frequent regurgitation of undigested food, progressive dysphagia, and a 40-lb (18 kg) weight loss over 4 months. Barium swallow revealed a large midesophageal diverticulum. A right thoracotomy and repair were planned after hospital admission for hydration and nutritional support.

The chest was entered above the sixth rib through a posterolateral thoracotomy. The right lung was deflated, and a right upper lobe adhesion to the chest wall was released. The azygos vein was transected to gain exposure to the diverticulum, which was associated with inflammation and adhesions in the posterior mediastinum. The diverticulum was resected and the esophagus repaired.

Because of persistent chylous leakage from the chest tubes, the patient was returned to the operating room 5 days later. Through the previous incision, the chest was opened and a leaking thoracic duct at the T2 level was identified. The duct was ligated, with additional ligatures placed on the duct at the T8 level. These areas were then covered with fibrin glue (Tisseel VH kit; Baxter Healthcare, Deerfield, IL) to ensure chylous stasis. There was no evidence of leak at the end of the procedure. However, within 4 days, the chest tube resumed its output of 2 L per day of chylous fluid. After discussing the options with the patient and his family, the decision to perform percutaneous repair was made. In the angiographic suite, bipedal lymphangiography was performed. Cutdown was performed on a lymphatic duct on the dorsum of each foot. Access was obtained with 28-gauge needles (Lymphangiography Set; Cook, Bloomington, IN), and 6 mL of iodinated oily contrast medium (Ethiodol; Savage Laboratory, Melville, NY) was injected on each side. An hour later, the cisterna chyli and thoracic duct were opacified.

Sonography was used to evaluate the tract from the skin to the cisterna chyli, and a 45° course through the left lobe of the liver was chosen. After administration of local anesthesia and conscious sedation, a 21-gauge needle was advanced through the anterior abdominal wall to puncture the cisterna chyli (Figs. 1A and 1B). On the third attempt, an 0.018-inch nitinol guidewire (Hytek; Microvena, White Bear Lake, MN) was passed into the thoracic duct. A 4-French catheter on a metal cannula (inner portion of the Accustick; Boston Scientific, Natick, MA) was advanced over the guidewire to the cisterna, and the catheter was then passed over the guidewire, which was supported by the cannula, into the duct. Aqueous contrast medium injection revealed a 3-mm duct with active extravasation at the T6-T7 level (Fig. 1C). Through the 4-French catheter, three 4-mm-diameter spiral coils (Vortex-18; Boston Scientific/Medi-Tech, Natick, MA) were deployed, which did not completely obstruct the flow of contrast medium. Moistened absorbable gelatin sponge (Gelfoam; Pharmacia & Upjohn, Kalamazoo, MI) cut into 1 x 2 mm pledgets was then injected and trapped by two additional coils in the more caudal thoracic duct, which proved to be occlusive (Fig. 1D). Because of the presence of fewer thrombotic components in chyle compared with blood, the coils probably did not immediately occlude the duct. The coils did confine the gelatin pledgets, and together proved to be occlusive.



View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A. 79-year-old man with persistent massive chylous effusion after esophagectomy and subsequent thoracic duct ligation. Anteroposterior (A) and magnified left anterior oblique (B) abdominal lymphangiograms show 2-mm retroperitoneal lymphatic duct (solid arrow) terminating at cisterna chyli (open arrow). Note incomplete filling of thoracic duct (arrowheads).

 


View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B. 79-year-old man with persistent massive chylous effusion after esophagectomy and subsequent thoracic duct ligation. Anteroposterior (A) and magnified left anterior oblique (B) abdominal lymphangiograms show 2-mm retroperitoneal lymphatic duct (solid arrow) terminating at cisterna chyli (open arrow). Note incomplete filling of thoracic duct (arrowheads).

 


View larger version (88K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C. 79-year-old man with persistent massive chylous effusion after esophagectomy and subsequent thoracic duct ligation. Radiograph obtained during contrast medium injection after selective thoracic duct catheterization with 4-French catheter (small arrows) reveals extravasation (large arrow) from disrupted thoracic duct at T7 level.

 


View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D. 79-year-old man with persistent massive chylous effusion after esophagectomy and subsequent thoracic duct ligation. Radiograph obtained after coil (arrows) and absorbable gelatin particle embolization shows stasis.

 

The next day chest tube output dropped to 120 mL of chyle. After 3 days, there was no further output and the chest tube was removed. The patient was transferred from the intensive care unit and was sent home 7 days after embolization.


Discussion
Top
Introduction
Subject and Methods
Discussion
References
 
High-output chylothorax caused by thoracic duct leak may be a result of esophageal surgery, lobectomy, lung transplant, coronary artery or aortic surgery, lymphangioleiomyomatosis, or trauma. This complication occurs in 1-4% of esophageal surgeries [1,2,3]. Because of the potential for septic complications associated with loss of protein and T cells, chylous output exceeding 800 mL/day may be life threatening [6]. Initial treatment consists of closed chest tube drainage with dietary restriction. Persistent high output may be treated with IV somatostatin-14 or etilefrine, pleurodesis, open surgical repair, or percutaneous embolization [4, 5, 7]. Lymphangiography is recommended before surgical intervention to show the thoracic duct anatomy and to identify the cause of the chylothorax [4]. Because of its minimal added morbidity, percutaneous embolization should be attempted before open surgery [5].

Of the 11 patients involved in the clinical prospective trial of the technique, the thoracic duct or cisterna chyli was identified in only five patients [5]. Catheterization of the thoracic duct was possible in all patients in whom it could be identified. Either the cisterna chyli or a major retroperitoneal lymphatic vessel larger than 1 mm in diameter with a direct course to the thoracic duct was required for successful catheterization [5, 8]. Of the five thoracic ducts catheterized, four were embolized, two of which had leakage totally controlled within a few days. In five of the six patients who could not be catheterized, chylous extravasation was identified from a small thoracic duct collateral or from a reconstituted duct [5]. Although the technical success rate was only 45%, the procedure produced no additional morbidity.

The procedure described by Cope [8] used an 8-French guiding cannula to prevent the small catheters and guidewires from buckling in the peritoneal cavity. We found, however, that the inner metal cannula provided adequate support and allowed the procedure to be performed through a 4-French access.

Chylothorax that persists beyond 5-7 days of conservative medical treatment should be treated promptly to avoid complications of nutritional and immunologic depletion [1,2,3,4]. Because of the low risks of the percutaneous procedure, it should be considered before open repair. The availability of nontraumatic yet firm guidewires and microcatheters make this approach a possible solution for an often difficult problem. Anatomic constraints, which prevent opacification of the cisterna chyli or retroperitoneal lymphatic supply to the thoracic duct, are the major obstacles to successful percutaneous repair.


References
Top
Introduction
Subject and Methods
Discussion
References
 

  1. Dugue L, Sauvanet A, Farges O, Goharin A, Le Mee J, Belghiti J. Output of chyle as an indicator of treatment for chylothorax complicating oesophagectomy. Br J Surg 1998;85:1147 -1149[Medline]
  2. Alexiou C, Watson M, Beggs D, Salama FD, Morgan WE. Chylothorax following oesophagogastrectomy for malignant disease. Eur J Cardiothorac Surg 1998;14:460 -466[Abstract/Free Full Text]
  3. Merigliano S, Molena D, Ruol A, et al. Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg 2000;119:453 -457[Abstract/Free Full Text]
  4. Browse NL, Allen DR, Wilson NM. Management of chylothorax. Br J Surg 1997;84:1711 -1716[Medline]
  5. Cope C, Salem R, Kaiser LR. Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol 1999;10:1248 -1254[Medline]
  6. Ross JK. A review of the surgery of the thoracic duct. Thorax 1961;16:12 -21
  7. Cerfolio RJ, Allen MS, Deschamps C, Trastek VF, Pairolero PC. Postoperative chylothorax. J Thorac Cardiovasc Surg 1996;112:1361 -1365[Abstract/Free Full Text]
  8. Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. J Vasc Interv Radiol 1998;9:727 -734[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
T MATSUMOTO, T YAMAGAMI, T KATO, T HIROTA, R YOSHIMATSU, T MASUNAMI, and T NISHIMURA
The effectiveness of lymphangiography as a treatment method for various chyle leakages
Br. J. Radiol., April 1, 2009; 82(976): 286 - 290.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. J. Boffa, M. J. Sands, T. W. Rice, S. C. Murthy, D. P. Mason, M. A. Geisinger, and E. H. Blackstone
A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 435 - 439.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
P. Narayan, N. Rahaman, T. F Molnar, and M. Caputo
Chylothorax Following Cardiac Surgery Caused by Unusual Lymphatic Anatomy
Asian Cardiovasc Thorac Ann, October 1, 2007; 15(5): e58 - e59.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
R. A. Lavis, J. A. Barrett, D. C. Kinsella, and R. G. Berrisford
Recurrent dysphagia after oesophagectomy caused by chylomediastinum
Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 68 - 70.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
A. B. Winick
Invited Commentary
RadioGraphics, November 1, 2003; 23(6): 1559 - 1560.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Mallick and A. R. Bodenham
Disorders of the lymph circulation: their relevance to anaesthesia and intensive care
Br. J. Anaesth., August 1, 2003; 91(2): 265 - 272.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffer, E. K.
Right arrow Articles by Fontaine, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffer, E. K.
Right arrow Articles by Fontaine, A. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS